These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31731542)

  • 1. Novel Hit Compounds as Putative Antifungals: The Case of
    Kritsi E; Matsoukas MT; Potamitis C; Detsi A; Ivanov M; Sokovic M; Zoumpoulakis P
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31731542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, Mechanism, and Inhibition of
    Marshall AC; Kidd SE; Lamont-Friedrich SJ; Arentz G; Hoffmann P; Coad BR; Bruning JB
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642940
    [No Abstract]   [Full Text] [Related]  

  • 3. The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.
    Song J; Zhai P; Zhang Y; Zhang C; Sang H; Han G; Keller NP; Lu L
    mBio; 2016 Feb; 7(1):e01919-15. PubMed ID: 26908577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cyp51A-based mechanism of azole resistance in Aspergillus fumigatus: Illustration by a new 3D Structural Model of Aspergillus fumigatus CYP51A protein.
    Liu M; Zheng N; Li D; Zheng H; Zhang L; Ge H; Liu W
    Med Mycol; 2016 May; 54(4):400-8. PubMed ID: 26768370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
    Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
    Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
    Alanio A; Denis B; Hamane S; Raffoux E; Peffault de Latour R; Menotti J; Amorim S; Touratier S; Bergeron A; Bretagne S
    Emerg Infect Dis; 2016 Jan; 22(1):157-8. PubMed ID: 26690934
    [No Abstract]   [Full Text] [Related]  

  • 7. Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
    Verweij PE; Chowdhary A; Melchers WJ; Meis JF
    Clin Infect Dis; 2016 Feb; 62(3):362-8. PubMed ID: 26486705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
    van der Linden JW; Arendrup MC; Melchers WJ; Verweij PE
    Emerg Infect Dis; 2016 Jan; 22(1):158-9. PubMed ID: 26691166
    [No Abstract]   [Full Text] [Related]  

  • 9. The Aspergillus fumigatus Mismatch Repair
    Dos Reis TF; Silva LP; de Castro PA; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Lind AL; Rokas A; Goldman GH
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.
    Meneau I; Coste AT; Sanglard D
    Med Mycol; 2016 Aug; 54(6):616-27. PubMed ID: 26933209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates.
    Meneau I; Sanglard D
    Med Mycol; 2005 May; 43 Suppl 1():S307-11. PubMed ID: 16110825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.
    Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Gallium as an Antifungal Agent.
    Bastos RW; Rossato L; Valero C; Lagrou K; Colombo AL; Goldman GH
    Front Cell Infect Microbiol; 2019; 9():414. PubMed ID: 31921699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signaling pathway is involved in non-CYP51 azole resistance in Aspergillus fumigatus.
    Li Y; Zhang Y; Lu L
    Med Mycol; 2019 Apr; 57(Supplement_2):S233-S238. PubMed ID: 30816964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
    Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
    Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
    Idelevich EA; Groß U; Becker K; Bader O
    Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus.
    Warrilow AG; Parker JE; Price CL; Nes WD; Kelly SL; Kelly DE
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7771-8. PubMed ID: 26459890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.